COSCIENS Biopharma Inc. (CSCI) — Net Asset Quality Index
COSCIENS Biopharma Inc. (CSCI) has a Net Asset Quality Index of 25.8% as of June 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $27.56 Million minus total liabilities of $20.46 Million yields net assets of $7.10 Million. A higher index indicates a stronger, lower-leverage balance sheet. For live market cap and overall valuation, see market value of COSCIENS Biopharma Inc..
Quality Index
Net Assets
Total Assets
Total Liabilities
COSCIENS Biopharma Inc. Net Asset Quality Index Over Time (1996–2024)
This chart shows how COSCIENS Biopharma Inc.'s Net Asset Quality Index has evolved across 29 annual periods from 1996 to 2024. As of June 2025, the index stands at 25.8%, representing net assets of $7.10 Million against total assets of $27.56 Million USD. See COSCIENS Biopharma Inc. shareholders equity for net asset value and shareholders' equity analysis.
Annual Net Asset Quality Index for COSCIENS Biopharma Inc. (1996–2024)
The table below presents the year-by-year Net Asset Quality Index for COSCIENS Biopharma Inc. from 1996 to 2024, covering 29 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. Also explore CSCI net asset momentum to track the company's year-over-year net asset growth rate.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 37.5% | $13.16 Million | $35.07 Million | $21.91 Million | ▼ -51.1 pp |
| 2023 | 88.6% | $21.04 Million | $23.75 Million | $2.71 Million | ▲ +3.0 pp |
| 2022 | 85.6% | $23.79 Million | $27.80 Million | $4.01 Million | ▼ -3.7 pp |
| 2021 | 89.3% | $21.74 Million | $24.35 Million | $2.61 Million | ▲ +6.1 pp |
| 2020 | 83.2% | $19.06 Million | $22.92 Million | $3.85 Million | ▲ +1.4 pp |
| 2019 | 81.8% | $17.08 Million | $20.88 Million | $3.79 Million | ▼ -9.8 pp |
| 2018 | 91.7% | $17.04 Million | $18.59 Million | $1.55 Million | ▲ +10.6 pp |
| 2017 | 81.1% | $17.93 Million | $22.11 Million | $4.19 Million | ▼ -3.8 pp |
| 2016 | 84.9% | $16.67 Million | $19.64 Million | $2.97 Million | ▲ +34.7 pp |
| 2015 | 50.2% | $5.68 Million | $11.32 Million | $5.64 Million | ▲ +22.9 pp |
| 2014 | 27.2% | $1.80 Million | $6.62 Million | $4.82 Million | ▲ +22.4 pp |
| 2013 | 4.8% | $229.62K | $4.79 Million | $4.56 Million | ▲ +4.4 pp |
| 2012 | 0.3% | $13.63K | $3.91 Million | $3.89 Million | ▼ -12.1 pp |
| 2011 | 12.4% | $507.11K | $4.09 Million | $3.58 Million | ▲ +35.6 pp |
| 2010 | -23.2% | $-654.90K | $2.82 Million | $3.47 Million | ▲ +26.3 pp |
| 2009 | -49.5% | $-1.31 Million | $2.65 Million | $3.96 Million | ▲ +9.2 pp |
| 2008 | -58.7% | $-1.59 Million | $2.70 Million | $4.29 Million | ▼ -92.6 pp |
| 2007 | 33.9% | $1.57 Million | $4.63 Million | $3.06 Million | ▲ +19.1 pp |
| 2006 | 14.7% | $260.64K | $1.77 Million | $1.51 Million | ▼ -4.3 pp |
| 2005 | 19.1% | $397.23K | $2.08 Million | $1.69 Million | ▲ +12.4 pp |
| 2004 | 6.6% | $94.89K | $1.43 Million | $1.33 Million | ▼ -23.8 pp |
| 2003 | 30.4% | $294.75K | $968.03K | $673.27K | ▲ +131.6 pp |
| 2002 | -101.2% | $-414.76K | $409.92K | $824.69K | ▲ +203.5 pp |
| 2001 | -304.6% | $-714.40K | $234.50K | $948.90K | ▲ +508.2 pp |
| 2000 | -812.8% | $-1.59 Million | $196.16K | $1.79 Million | ▼ -160.7 pp |
| 1999 | -652.2% | $-1.31 Million | $201.16K | $1.51 Million | ▼ -432.2 pp |
| 1998 | -220.0% | $-714.89K | $324.95K | $1.04 Million | ▼ -291.8 pp |
| 1997 | 71.8% | $6.57 Million | $9.15 Million | $2.59 Million | ▲ +28.7 pp |
| 1996 | 43.0% | $5.84 Million | $13.57 Million | $7.73 Million | — |